BDBM39707 MLS000535546::N'-(4-butoxyphenyl)-N-[2-(1-cyclohexenyl)ethyl]oxamide::N'-(4-butoxyphenyl)-N-[2-(cyclohexen-1-yl)ethyl]ethanediamide::N'-(4-butoxyphenyl)-N-[2-(cyclohexen-1-yl)ethyl]oxamide::N-(4-butoxyphenyl)-N'-[2-(1-cyclohexen-1-yl)ethyl]ethanediamide::SMR000142982::cid_2194059

SMILES O=C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCC(=O)N[C@@H](c1ccccc1)c1ccc(C2CC2)c(F)n1)N[C@@H](c1ccccc1)c1ccc(C2CC2)c(F)n1

InChI Key InChIKey=ONFIRCPVRJBFGK-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 39707   

TargetGlycogen [starch] synthase, muscle(Human)
Maze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 39707BDBM39707(US20260098025, Compound 3)
Affinity DataIC50: 5.71E+3nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2026
Entry Details
US Patent